We talk with Dr Kiran Reddy about the plans for the RC-222 treatment program with the goal of developing a treatment for SCN2A gain-of-function epilepsies.
When Alex Nemiroff’s son was born, he was determined to work towards finding treatments for SCN2A, and is now CEO of RogCon with a treatment in development.
Outstanding plenary from Greg Pratt #HGSA2022ASM discussing #inequities in health outcomes for Aboriginal and Torres Strait Islander people + how their careful consultation on country is improving #equity of access to #genomics & #culturalsafety
2It was great to be able to present @swanaus parents views around genomic data, DNA samples and consent this morning at #HGSA2022. #SWAN parents want greater control over their child’s genomic data including who has access to it and how it is used.
© All rights reserved. SCN2A Australia | Privacy Policy
